Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vyteris, a manufacturer of active patch transdermal drug delivery system, has appointed Haro Hartounian as president and Joseph Himy as CFO to lead the company in its pursuit of several strategic initiatives.
Subscribe to our email newsletter
Most recently chief technology officer for Vyteris, Mr Hartounian previously served as a director and CEO of Protagenic Therapeutics, a biotechnology company he founded in 2006 to treat neurological disorders.
A long-time member of the Vyteris team, Mr Himy transitions from vice president of finance to CFO at the company. He previously was also principal accounting officer and controller for Vyteris.
Vyteris also reaffirmed its strategy to pursue additional collaborative development and licensing opportunities with pharmaceutical companies with existing drug lines to enhance performance and to potentially extend valuable patent protection.